Bill Steinkrauss

Bill Steinkrauss is an accomplished financial professional with extensive experience in the biotechnology sector. Currently serving as President of OWL CFO Consulting and Chief Financial Officer for both ILiAD Biotechnologies and OcuTerra Therapeutics, Bill also holds the position of Interim Chief Financial Officer at PureTech Health. Additionally, Bill is a Board Member for COMPASS, Community Providers of Adolescent Services. Previous roles include Chief Financial Officer and Chief Administrative Officer at Curis, Director of Finance at OvaScience, and various managerial positions at Cubist Pharmaceuticals and PwC. Bill holds a Bachelor of Science in Finance and Accounting and a Master of Science in Accounting from Boston College.